572 related articles for article (PubMed ID: 8906895)
1. The use of therapeutic drug monitoring to optimise immunosuppressive therapy.
Tsunoda SM; Aweeka FT
Clin Pharmacokinet; 1996 Feb; 30(2):107-40. PubMed ID: 8906895
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive drugs in paediatric liver transplantation.
van Mourik ID; Kelly DA
Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.
del Mar Fernández De Gatta M; Santos-Buelga D; Domínguez-Gil A; García MJ
Clin Pharmacokinet; 2002; 41(2):115-35. PubMed ID: 11888332
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
Dunn CJ; Wagstaff AJ; Perry CM; Plosker GL; Goa KL
Drugs; 2001; 61(13):1957-2016. PubMed ID: 11708766
[TBL] [Abstract][Full Text] [Related]
5. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine.
Armstrong VW; Oellerich M
Clin Biochem; 2001 Feb; 34(1):9-16. PubMed ID: 11239509
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitors in renal transplantation: what is the best option?
Tanabe K
Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.
Monchaud C; Marquet P
Clin Pharmacokinet; 2009; 48(7):419-62. PubMed ID: 19691367
[TBL] [Abstract][Full Text] [Related]
9. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
10. Clinically significant drug interactions with new immunosuppressive agents.
Mignat C
Drug Saf; 1997 Apr; 16(4):267-78. PubMed ID: 9113494
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus: a further update of its use in the management of organ transplantation.
Scott LJ; McKeage K; Keam SJ; Plosker GL
Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.
Spencer CM; Goa KL; Gillis JC
Drugs; 1997 Dec; 54(6):925-75. PubMed ID: 9421697
[TBL] [Abstract][Full Text] [Related]
14. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine and tacrolimus.
Vaden SL
Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):161-6. PubMed ID: 9283240
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
Plosker GL; Foster RH
Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
[TBL] [Abstract][Full Text] [Related]
17. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.
Wilde MI; Goa KL
Drugs; 1996 May; 51(5):865-94. PubMed ID: 8861551
[TBL] [Abstract][Full Text] [Related]
18. Clinically significant drug interactions with cyclosporin. An update.
Campana C; Regazzi MB; Buggia I; Molinaro M
Clin Pharmacokinet; 1996 Feb; 30(2):141-79. PubMed ID: 8906896
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
Noble S; Markham A
Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
Staatz CE; Tett SE
Clin Pharmacokinet; 2004; 43(10):623-53. PubMed ID: 15244495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
